Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The year Leah Mayfield died, Bayer HealthCare made $600 million on its popular birth control pill, Yaz. The drug, also known by the brand name Yasmin and the generic brand Ocella, was touted for the added benefit of stomping out the bothersome symptoms of severe premenstrual syndrome, or premenstrual dysphoric disorder (PMDD). It is the combination of ethinyl estradiol and the diuretic drospirenone that make Yaz different than other birth control pills. But that combination has proven deadly to numerous women who have taken it, including 20-year-old Leah.

Read the rest of this entry »